Edition 25, 2013
Hansen Family Prize: Bayer Honors Cancer Researcher

Hunting Down the Silent Foe

  • Hunting down the silent foe.
  • Professor Hans-Georg Rammensee, Head of the Immunology Department at the Interfaculty Institute of Cell Biology at the University of Tübingen and co-founder of immatics.
Hunting down the silent foe.

An effective treatment for various types of cancer – with virtually no side effects: researchers at the biotech firm immatics are working on the first therapeutic cancer vaccination with a multipeptide vaccine. The concept was developed by Professor Hans-Georg Rammensee, and in 2013 won him the Hansen Family Prize, awarded by Bayer to honor researchers for pioneering achievements in medically oriented research.

Find out here exactly how the principle of cancer vaccination works:

International Users
This website is checked, operated and updated by BAYER at Leverkusen, Germany. It is intended for international use. However BAYER gives no guarantee that the details presented on this website are correct worldwide, and, in particular, that products and services will be available with the same appearance, in the same sizes or on the same conditions throughout the world. Should you call up this website or download contents, please note that it is your own responsibility to ensure that you act in compliance with local legislation applicable in that place.Products mentioned on this website may come in different packaging, in different package sizes, or with different lettering or markings, depending on the country.
In the USA the business of the Bayer Group is conducted by Bayer Corporation. Customers in the USA are requested to address to this entity.